Join a clinical study to help us research an investigational next-generation anthrax vaccine.
Together we can research a vaccine aiming to produce a faster immune response against anthrax exposure.
The Velocity Study is looking at an investigational vaccine to potentially protect people who have been exposed to anthrax bacteria from infection.
You may be able to participate if you are:
- 18 to 65 years of age
- generally healthy
- not currently pregnant or breastfeeding (if you are a woman who is able to have children).
If you take part, you will be in the Velocity Study for about 15 months. You will need to visit the study center 5 times, receive a total of 3 vaccinations, and receive 5 follow-up phone calls.
You will not be exposed to anthrax during the study.
The investigational vaccine is bacteria-free.
Want to know more?
To learn more, please contact: (912) 623-2240.
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
Meridian Clinical Research
340 Eisenhower Dr #1200
Savannah, GA 31406
Submit Your Information
About Meridian Clinical Research
Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For almost 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.